LXRX CIK: 1062822

Lexicon Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.30
FY22:
0.14
FY23:
1.12
FY24:
30.5
FY25:
49.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.1
FY22:
−101
FY23:
−172
FY24:
−197
FY25:
−48.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−86.7
FY22:
−98.7
FY23:
−163
FY24:
−184
FY25:
−41.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.8
FY22:
−102
FY23:
−177
FY24:
−200
FY25:
−50.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.8
FY22:
−102
FY23:
−177
FY24:
−200
FY25:
−50.3

All amounts in millions USD Data sources:SEC EDGARTwelve Data